8:00 – 8:15 AM |
Welcome & Opening Remarks from the chairs
Dr. Culver, Dr. Jacono, Dr. Shatat
|
Session 1: Rethinking COPD Phenotypes
|
8:15 – 8:40 AM |
Jessica Bon: COPD, extrapulmonary complications, and where do we go from here
|
8:40 – 9:05 AM |
Russ Bowler: Accelerated aging in large COPD consortia
|
9:05 – 9:30 AM |
Mike Wells: Alpha–1 Antitrypsin and COPD – Exploring New Therapeutics
|
9:30 – 10:00 AM |
Panel Discussion: How we phenotype patients beyond GOLD stages
Panelists: Jessica Bon, Mike Wells, Russ Bowler
|
10:00 – 10:15 AM |
Morning Break – Visit Exhibits
|
Session 2: Environmental & Behavioral Influences
|
10:15 – 10:40 AM |
Maeve Macmurdo: Air Pollution and COPD
|
10:40 – 11:05 AM |
Joanne McKell: Smoking Cessation from the VA perspective
|
11:05 – 11:30 AM |
Mirna Ayache: COPD & SDOH – Metro Health Perspective
|
11:30 – 11:55 AM |
Vick Tejwani: Biologic Therapy for COPD
|
11:55 – 12:45 PM |
Lunch Break & Visit Exhibits
|
Session 3: Therapeutic Strategies
|
12:45 – 1:05 PM |
Andy Lewis: Inhaler Therapy for COPD
|
1:05 – 1:25 PM |
Amy Attaway: Screening for Sarcopenia
|
1:25 – 1:50 PM |
Umur Hatipoğlu: Noninvasive Ventilation for COPD
|
1:50 – 2:20 PM |
Andrew Rich & Danielle Wisen: Interdisciplinary COPD Care
|
2:20 – 2:40 PM |
Afternoon Break – Visit Exhibits
|
2:40 – 3:10 PM |
See Wei Low & Sameer Avasarala: Endobronchial valve therapy
|
3:10 – 3:35 PM |
Sid Murthy: Lung volume reduction surgery
|
3:35 – 4:00 PM |
Jason Turowski: Lung Transplant
|
4:00 – 4:15 PM |
Umur Hatipoğlu: Wrap–Up & Final Remarks
|
